Help | RSS Feed



Chembio Diagnostics Inc. (NASD:CEMI) Seasonal Chart

Seasonal Chart Analysis

Analysis of the Chembio Diagnostics Inc. (NASD:CEMI) seasonal charts above shows that a Buy Date of April 17 and a Sell Date of July 23 has resulted in a geometric average return of 5.9% above the benchmark rate of the S&P 500 Total Return Index over the past 19 years. This seasonal timeframe has shown positive results compared to the benchmark in 13 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 19 years by an average of 30.48% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Chembio Diagnostics Inc is a US-based company which develops, manufactures, and commercializes point-of-care diagnostic tests which detect infectious diseases. The products of the company include rapid tests for the detection of HIV 1/2 antibodies and a multiplex rapid test for the detection of HIV and syphilis antibodies. Most of the company’s revenue comes from the sale of ASC 605. The company offered rapid medical tests are offered in Africa, Asia, Europe and Middle East, Latin America and the United States, of which key revenue is derived from the Latin America.

To download CEMI seasonal chart data, please log in or Subscribe.

 

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Sponsored By...
Seasonal Advantage Portfolio by CastleMoore